Medical News

RSS

ONA President’s statement on Ontario provincial budget

Ontario Nurses' Association (ONA) President Linda Haslam-Stroud, RN says that today's provincial budget means more service and nursing cuts for patients in this province.

26 Mar 2010

RXi Pharmaceuticals obtains commitments to purchase 2.7M shares of common stock at $6.00 per share

RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference, announced today that it has obtained commitments from several investors to purchase 2.7 million shares of its common stock at $6.00 per share and warrants to purchase 540,000 shares of its common stock for gross proceeds of $16.2 million.

26 Mar 2010

Parties vie for political momentum after health vote

The health care debate has already become a proxy for 2010 election fights, with candidates in both parties wielding the issue, according to The Wall Street Journal: "In Kentucky, the two leading Democrats seeking an open Senate seat are battling over who has been most committed to the health-care law." Meanwhile, "[two] potential 2012 presidential candidates, Republicans Sarah Palin and Mitt Romney, both issued fund-raising appeals to their supporters, saying they would use the money to fight for the GOP position on the health-care law" (Wallsten, 3/25).

26 Mar 2010

FDA grants tentative approval for Teva Pharmaceutical Industries' generic Argatroban ANDA

Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration (FDA) has granted tentative approval for the Company's Abbreviated New Drug Application (ANDA) to market a generic version of the anticoagulant, Argatroban® injection, 100mg/mL.

26 Mar 2010

Early screening for diabetes and kidney disease can improve health outcomes

Millions of Americans may have chronic kidney disease (CKD) and not know it, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN).

26 Mar 2010

New report urges government to ban smoking in cars to limit children's exposure to passive smoke

A new report released by the Tobacco Advisory Group of the Royal College of Physicians urges the government to ban smoking in cars and other public vehicles to limit children's exposure to passive smoke.

26 Mar 2010

SMA Foundation completes biomarker study for Spinal Muscular Atrophy

The Spinal Muscular Atrophy (SMA) Foundation, a nonprofit organization dedicated to accelerating the development of a treatment for SMA, is pleased to announce the completion of a pilot study to identify Biomarkers for Spinal Muscular Atrophy (BforSMA) and the discovery of over 400 candidate biomarkers.

26 Mar 2010

Interim results from ZALBIN Phase 2B trial in chronic hepatitis C patients announced

Human Genome Sciences, Inc. today announced interim results through Week 12 following the end of treatment in a Phase 2b clinical trial conducted by Novartis to evaluate the safety and efficacy of ZALBIN™ (albinterferon alfa-2b), an investigational agent, administered monthly in combination with ribavirin in 391 treatment-naive patients with genotypes 2 and 3 chronic hepatitis C virus. The primary efficacy endpoint is sustained virologic response (SVR) at Week 48 (24 weeks following the end of treatment).

26 Mar 2010

Artist and scientist examine principles of visual perception

A novel research project spearheaded by the University of Leicester and part-funded by The Leverhulme Trust aims to shed new light on the way people perceive art.

26 Mar 2010

New PreXion3D Volumetric Imaging Software for 3D CBCT system launched

PreXion, Inc., the leader in high quality 3D Cone Beam Imaging systems for dentistry, today announced that it has launched and started shipping new PreXion3D Volumetric Imaging Software for its 3D Cone Beam Computed Tomography system for dentistry. This new product incorporates a range of advanced features including tools for implant planning and placement and an enhanced version of its PrexViewer software.

26 Mar 2010

Renowned experts discuss key statistics of health care reform at 2010 Keenan Summit

Keenan & Associates, the largest privately-held insurance brokerage and consulting firm in California, convened its sixth annual Keenan Summit on March 3, 2010, in Pasadena, Calif., and on March 4, 2010, in Berkeley. The theme for this year's summit was "Navigating Through Unprecedented Times: Today's Challenges. Tomorrow's Solutions."

26 Mar 2010

FDA approves Mirapex ER tablets for signs and symptoms of idiopathic PD

Boehringer Ingelheim Pharmaceuticals, Inc., today announced that the U.S. Food and Drug Administration has approved once-daily Mirapex ER® (pramipexole dihydrochloride) extended-release tablets for the signs and symptoms of idiopathic Parkinson's disease, which includes early and advanced PD. PD is the second most common chronic neurological disorder in older adults after Alzheimer's. Parkinson's disease has no cure.

26 Mar 2010

Overhaul will affect other economic sectors, not just health care

Health-overhaul legislation signed into law this week will affect not only America's health care industry, but the broader economy, too, The Christian Science Monitor reports. The overhaul could help create jobs. "But the legislation also means tax hikes, mainly on the highest-income Americans. And provisions designed to curb healthcare costs probably aren't strong enough to put a big dent in medical inflation - or federal budget deficits" (Trumbull, 3/24).

26 Mar 2010

Dyax to use proceeds of public offering for commercialization and distribution activities of KALBITOR

Dyax Corp. today announced the pricing of an underwritten public offering of 17,000,000 shares of its common stock at a price to the public of $3.25 per share. The gross proceeds from the sale of shares, after underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $51.8 million. The offering is expected to close on or about March 30, 2010, subject to customary closing conditions.

26 Mar 2010

Obama's closed-door signing of executive order on abortion funding raises objections

President Barack Obama signed an executive order Wednesday pledging that no federal funding will be used for abortion under the new health bill.

26 Mar 2010

Positive results from Stage A pivotal study of 2009 A/H1N1 VLP pandemic influenza vaccine

Novavax, Inc. announced today positive results from the entire 1,000 subject Stage A of its two-stage pivotal study evaluating the safety and immunogenicity of Novavax's unadjuvanted 2009 A/H1N1 virus-like particle pandemic influenza vaccine.

26 Mar 2010

With reform, community health centers will see federal funds double

The Wall Street Journal reports that the health overhaul bill signed by President Barack Obama will increase spending "by $10 billion over five years for [some] clinics, known as community health centers. An additional $2.5 billion is included in a package of changes to that bill, which is expected to get final approval in Congress as soon as this week."

26 Mar 2010

Constitutional expert says new health reform law should stand up to legal court challenges

The newly signed health care reform law should stand up well to legal court challenges, says constitutional expert and political scientist Mark Graber of the University of Maryland.

26 Mar 2010

New gateway may be lifesaver for patients with AML: Study

Canadian researchers have discovered a previously hidden channel to attack leukemia and other cancer cells, according to a new study published in the Journal of Biological Chemistry. The findings from the Universit- de Montr-al, Maisonneuve-Rosemont Hospital and Universit- Laval may change the way doctors treat cancer patients.

26 Mar 2010

Santarus enrolls 510 patients in Phase III clinical program for budesonide MMX

Santarus, Inc., a specialty biopharmaceutical company, today announced the completion of enrollment of 510 patients in a U.S. Phase III clinical study to evaluate budesonide MMX® administered over eight weeks for the induction of remission of mild or moderate active ulcerative colitis. This is the second Phase III clinical study being conducted in collaboration with Cosmo Technologies Ltd., a subsidiary of Cosmo Pharmaceuticals SpA, as part of the budesonide MMX Phase III clinical program for U.S. registration.

26 Mar 2010

Medical News

ONA President’s statement on Ontario provincial budget

RXi Pharmaceuticals obtains commitments to purchase 2.7M shares of common stock at $6.00 per share

Parties vie for political momentum after health vote

FDA grants tentative approval for Teva Pharmaceutical Industries' generic Argatroban ANDA

Early screening for diabetes and kidney disease can improve health outcomes

New report urges government to ban smoking in cars to limit children's exposure to passive smoke

SMA Foundation completes biomarker study for Spinal Muscular Atrophy

Interim results from ZALBIN Phase 2B trial in chronic hepatitis C patients announced

Artist and scientist examine principles of visual perception

New PreXion3D Volumetric Imaging Software for 3D CBCT system launched

Renowned experts discuss key statistics of health care reform at 2010 Keenan Summit

FDA approves Mirapex ER tablets for signs and symptoms of idiopathic PD

Overhaul will affect other economic sectors, not just health care

Dyax to use proceeds of public offering for commercialization and distribution activities of KALBITOR

Obama's closed-door signing of executive order on abortion funding raises objections

Positive results from Stage A pivotal study of 2009 A/H1N1 VLP pandemic influenza vaccine

With reform, community health centers will see federal funds double

Constitutional expert says new health reform law should stand up to legal court challenges

New gateway may be lifesaver for patients with AML: Study

Santarus enrolls 510 patients in Phase III clinical program for budesonide MMX

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News